Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Davis

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Agents and Actions|September 1, 1992
Oral, anti-inflammatory activity of a potent, selective, protein kinase C inhibitorM J Mulqueen, D Bradshaw, P D Davis, et al.
FEBS Letters|November 18, 1991
A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuliR E Muid, M M Dale, P D Davis, et al.
Current Medicinal Chemistry|March 23, 2004
4-thiophenoxy-N-(3,4,5-trialkoxyphenyl)pyrimidine-2-amines as potent and selective inhibitors of the T-cell tyrosine kinase p56lckD F C Moffat, R A Allen, S E Rapecki, et al.
Journal of Medicinal Chemistry|March 20, 1992
Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivityP D Davis, L H Elliott, W Harris, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Agents and Actions|September 1, 1992
Oral, anti-inflammatory activity of a potent, selective, protein kinase C inhibitorM J Mulqueen, D Bradshaw, P D Davis, et al.
FEBS Letters|November 18, 1991
A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuliR E Muid, M M Dale, P D Davis, et al.
Current Medicinal Chemistry|March 23, 2004
4-thiophenoxy-N-(3,4,5-trialkoxyphenyl)pyrimidine-2-amines as potent and selective inhibitors of the T-cell tyrosine kinase p56lckD F C Moffat, R A Allen, S E Rapecki, et al.
Journal of Medicinal Chemistry|March 20, 1992
Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivityP D Davis, L H Elliott, W Harris, et al.
Pageof 4